Sandbox:Ifeoma Anaya: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
[[File:Mitoses in neuroendocrine tumor.jpg|thumb|200px|none| Mitosis in neuroendocrine tumor. [https://commons.wikimedia.org/wiki/File:Mitoses_in_neuroendocrine_tumor.jpg Source: Wikimedia commons]]] | [[File:Mitoses in neuroendocrine tumor.jpg|thumb|200px|none| Mitosis in neuroendocrine tumor. [https://commons.wikimedia.org/wiki/File:Mitoses_in_neuroendocrine_tumor.jpg Source: Wikimedia commons]]] | ||
{| | |||
|+ '''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders''' | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | - | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | - | |||
|} | |||
Revision as of 18:28, 28 August 2020
Practice here
| Criteria | Symptomatic WM | Asymptomatic WM | IgM-Related Disorders | MGUS |
|---|---|---|---|---|
| IgM monoclonal protein | + | + | + | + |
| Bone marrow infiltration | + | + | - | - |
| Symptoms attributable to IgM | + | - | + | - |
| Symptoms attributable to tumor infiltration | + | - | - | - |
References
- ↑ Kiran U, Aggarwal S, Choudhary A, Uma B, Kapoor PM (2017). "The blalock and taussig shunt revisited". Ann Card Anaesth. 20 (3): 323–330. doi:10.4103/aca.ACA_80_17. PMC 5535574. PMID 28701598.